Target intelligence / Profile preview

Renal tubular epithelial regeneration

Molecular classification
Other
01

Overview

Renal tubular epithelial regeneration" refers to the **biological process** by which damaged or lost renal tubule epithelial cells are replaced following injury. In healthy kidneys, these cells are typically quiescent and do not divide. However, upon acute damage—such as from ischemia-reperfusion injury or toxic insults—the surviving proximal tubule cells can dedifferentiate into a regenerative phenotype known as scattered tubular-like cells (STCs). These STCs exhibit increased proliferation and resilience to further damage. The current consensus is that most if not all proximal tubule cells have the capacity to become regenerative STCs in response to injury, rather than there being a fixed progenitor population[2][3]. This regenerative response is crucial for recovery from acute kidney injuries but can be overwhelmed in severe or chronic conditions. Notably, "renal tubular epithelial regeneration" is **not** itself a molecular target such as an enzyme or receptor; it describes an overall tissue-level phenomenon involving multiple cellular pathways and markers. Therefore, it should not be classified as an individual therapeutic target for drug development purposes[2][3].

Other names
Tubular epithelial regenerationRenal tubular cell regenerationTubular cell repairKidney tubular epithelium regeneration
02

Biological functions

Cell proliferationCell dedifferentiationTissue repairRegeneration after injuryApoptosis resistance (in context of scattered tubular cells)
03

Disease associations

Acute kidney injuryChronic kidney diseaseOther renal injuries and nephropathies
04

Biomarkers

KIM-1 (Kidney Injury Molecule 1)Annexin A3CD44

Beyond the preview

Go deeper on Renal tubular epithelial regeneration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renal tubular epithelial regeneration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call